QQ客服 官方微博 反馈留言

	Pharmacokinetics and pharmacokinetic/pharmacodynamic relationship of vicagrel, a novel thienopyridine P2Y(12) inhibitor, compared with clopidogrel in healthy Chinese subjects following single oral dosing
	Liu, Cai; Zhang, Yifan; Chen, Weili; Lu, Youming; Li, Wei; Liu, Yongqiang; Lai, Xiaojuan; Gong, Yanchun; Liu, Xuefang; Li, Yongguo
刊名	EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
	2019
卷号	127
关键词	Vicagrel Clopidogrel P2Y(12) inhibitor Pharmacokinetics Active metabolite Thienopyridine
ISSN号	0928-0987
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3598299
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Liu, Cai,Zhang, Yifan,Chen, Weili,et al. Pharmacokinetics and pharmacokinetic/pharmacodynamic relationship of vicagrel, a novel thienopyridine P2Y(12) inhibitor, compared with clopidogrel in healthy Chinese subjects following single oral dosing[J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES,2019,127.
APA	Liu, Cai.,Zhang, Yifan.,Chen, Weili.,Lu, Youming.,Li, Wei.,...&Zhong, Dafang.(2019).Pharmacokinetics and pharmacokinetic/pharmacodynamic relationship of vicagrel, a novel thienopyridine P2Y(12) inhibitor, compared with clopidogrel in healthy Chinese subjects following single oral dosing.EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES,127.
MLA	Liu, Cai,et al."Pharmacokinetics and pharmacokinetic/pharmacodynamic relationship of vicagrel, a novel thienopyridine P2Y(12) inhibitor, compared with clopidogrel in healthy Chinese subjects following single oral dosing".EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES 127(2019).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。